Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Loa Loa (eye worm) | lipase | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma brucei | lipase domain protein, putative | 0.1189 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Trypanosoma cruzi | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma brucei | lipase-like protein, putative | 0.0023 | 0.0025 | 0.0025 |
Onchocerca volvulus | 0.1189 | 1 | 1 | |
Plasmodium falciparum | lipase, putative | 0.0023 | 0.0025 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Giardia lamblia | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.003 | 0.0089 | 0.0089 |
Echinococcus multilocularis | sn1 specific diacylglycerol lipase beta | 0.1189 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0023 | 0.0025 | 0.5 |
Trypanosoma cruzi | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Leishmania major | hypothetical protein, conserved | 0.0023 | 0.0025 | 0.0025 |
Leishmania major | class 3 lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase domain protein, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase domain protein, putative | 0.0023 | 0.0025 | 0.0025 |
Entamoeba histolytica | lipase, putative | 0.0023 | 0.0025 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Toxoplasma gondii | lipase | 0.0023 | 0.0025 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma brucei | lipase domain protein, putative | 0.1189 | 1 | 1 |
Toxoplasma gondii | lipase | 0.0023 | 0.0025 | 0.5 |
Loa Loa (eye worm) | lipase | 0.1189 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0023 | 0.0025 | 0.0025 |
Leishmania major | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Echinococcus granulosus | sn1 specific diacylglycerol lipase beta | 0.1189 | 1 | 1 |
Leishmania major | lipase precursor-like protein | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1189 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0023 | 0.0025 | 0.0025 |
Loa Loa (eye worm) | lipase | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1189 | 1 | 1 |
Brugia malayi | Lipase family protein | 0.0023 | 0.0025 | 0.0025 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.002 | 0 | 0.5 |
Toxoplasma gondii | lipase | 0.0023 | 0.0025 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.1189 | 1 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0023 | 0.0025 | 0.0025 |
Toxoplasma gondii | lipase | 0.0023 | 0.0025 | 0.5 |
Giardia lamblia | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Trichomonas vaginalis | lipase containing protein, putative | 0.1189 | 1 | 1 |
Trypanosoma brucei | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Brugia malayi | Lipase family protein | 0.0023 | 0.0025 | 0.0025 |
Entamoeba histolytica | lipase, putative | 0.0023 | 0.0025 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Leishmania major | hypothetical protein, unknown function | 0.0023 | 0.0025 | 0.0025 |
Leishmania major | hypothetical protein, conserved | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | Triglyceride lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Leishmania major | hypothetical protein, unknown function | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma brucei | Triglyceride lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Trypanosoma brucei | triacylglycerol lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase-like protein, putative | 0.0023 | 0.0025 | 0.0025 |
Entamoeba histolytica | lipase, putative | 0.0023 | 0.0025 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma brucei | Triglyceride lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma brucei | Lipase (class 3), putative | 0.0023 | 0.0025 | 0.0025 |
Leishmania major | lipase, putative;with=GeneDB:LinJ31_V3.0860 | 0.0023 | 0.0025 | 0.0025 |
Brugia malayi | Lipase family protein | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | Lipase (class 3), putative | 0.0023 | 0.0025 | 0.0025 |
Trichomonas vaginalis | lipase containing protein, putative | 0.1189 | 1 | 1 |
Brugia malayi | Lipase family protein | 0.0023 | 0.0025 | 0.0025 |
Trypanosoma cruzi | lipase, putative | 0.0023 | 0.0025 | 0.0025 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Entamoeba histolytica | lipase, putative | 0.0023 | 0.0025 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0023 | 0.0025 | 0.5 |
Trypanosoma brucei | lipase domain protein, putative | 0.0023 | 0.0025 | 0.0025 |
Leishmania major | lipase domain protein, putative | 0.0023 | 0.0025 | 0.0025 |
Brugia malayi | Cytochrome P450 family protein | 0.003 | 0.0089 | 0.0089 |
Schistosoma mansoni | lipase | 0.0023 | 0.0025 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IZ (functional) | = 8 mm | Antifungal activity against Candida albicans at 250 ug/ml after 72 hrs by disc diffusion method | ChEMBL. | No reference |
IZ (functional) | = 8 mm | Antibacterial activity against Escherichia coli at 250 ug/ml after 24 to 45 hrs by disc diffusion method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.